HELLO INSIDE is a technology company.
HELLO INSIDE has raised $2.0M across 1 funding round.
HELLO INSIDE has raised $2.0M in total across 1 funding round.
HELLO INSIDE has raised $2.0M in total across 1 funding round.
HELLO INSIDE's investors include 3VC, BoxOne Ventures, DEPO Ventures, Evolution Equity Partners, Octopus Ventures, Eric Demuth, Matthias Wilrich.
Hello Inside is an Austria-based metabolic health startup founded in 2021 that builds an AI-powered platform using continuous glucose monitoring (CGM) to deliver personalized health insights, primarily targeting women.[1][2][3][5] The product integrates third-party CGM sensors with AI analysis of lifestyle data—like food, movement, stress, and sleep—to provide actionable recommendations on glycemic responses and metabolic health, helping users achieve goals such as weight management.[1][2][3] It serves women seeking data-driven self-care, solving the problem of one-size-fits-all diets by offering holistic, individualized nutrition and behavior change tools that integrate seamlessly with devices like Oura Ring and Apple Health; early metrics show strong engagement with over 10 app interactions per day and 80% of users hitting weight goals in 30 days.[2][3]
The company recently raised €1.65 million in seed funding from Verge Fund (backed by DocMorris), Kapa Ventures, and angels including Lea-Sophie Cramer and Eric Demuth, fueling clinical trials and B2B expansion amid rising demand for FemTech solutions.[2][3]
Hello Inside was founded in 2021 in Austria by Mario Aichlseder (CEO & Co-Founder), Jürgen Furian (COO & Co-Founder), Dr. Anne Latz (CMO & Co-Founder), and Vincent Weber (CTO & Co-Founder), a team blending tech, operations, medical expertise, and engineering to tackle metabolic health gaps.[1][5] The idea emerged from recognizing how people—especially women—have "lost touch with their bodies" due to oversimplified health advice, prompting a shift toward sensor-driven, personalized self-care over generic diets.[5] Early traction built on CGM technology's potential for consumer insights into glycemic responses, evolving into a women-focused platform that gained momentum through high user engagement and the 2024 seed round, validating its model in the burgeoning FemTech space.[2][3]
Hello Inside rides the FemTech and computational healthcare wave, capitalizing on CGM's shift from diabetes management to mainstream wellness, where market forces like rising women's health awareness and AI personalization favor scalable, data-driven solutions.[1][2][3] Timing aligns with post-pandemic demand for preventive metabolic health amid obesity and hormonal challenges unique to women, amplified by integrations with wearables in a $50B+ digital health market.[2][3] It influences the ecosystem by closing knowledge gaps through community-driven insights, paving the way for B2B applications and clinical validation in a sector projected to grow rapidly.[3]
Hello Inside is poised to scale its engaging CGM platform via fresh funding, prioritizing clinical trials, B2B partnerships, and global expansion to solidify FemTech leadership.[2][3] Trends like AI-health intersections and wearable ubiquity will propel it, potentially evolving into a full lifestyle ecosystem influencing preventive care norms. As metabolic personalization matures, expect Hello Inside to empower more users toward sustained wellness, transforming data into quiet confidence.
HELLO INSIDE has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2024 | $2.0M Seed | 3VC, BoxOne Ventures, DEPO Ventures, Evolution Equity Partners, Octopus Ventures, Eric Demuth, Matthias Wilrich |